Literature DB >> 11412256

Long-term results of treating hepatic colorectal metastases with cryosurgery.

T J Ruers1, J Joosten, G J Jager, T Wobbes.   

Abstract

BACKGROUND: The purpose of this study was to determine the long-term efficacy of cryosurgery as an adjunct to hepatic resection in patients with colorectal liver metastases not amenable to resection alone.
METHODS: Thirty patients met the following inclusion criteria: metastases confined to the liver and judged irresectable, ten or fewer metastases, cryosurgery alone or in combination with hepatic resection allowed tumour clearance.
RESULTS: Median follow-up was 26 (range 9--73) months. Overall 1- and 2-year survival rates were 76 and 61 per cent respectively. Median survival was 32 months. Disease-free survival at 1 year was 35 per cent, at 2 years 7 per cent. Six patients developed recurrence at the site of cryosurgery; given that the total number of cryosurgery-treated lesions was 69 the local recurrence rate was 9 per cent.
CONCLUSION: In patients with colorectal liver metastases, local ablative techniques can be used as an effective adjunct to hepatic resection to obtain tumour clearance.

Entities:  

Mesh:

Year:  2001        PMID: 11412256     DOI: 10.1046/j.1365-2168.2001.01766.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

Review 1.  Treatment for multiple bilobar liver metastases of colorectal cancer.

Authors:  Hiroshi Shimada; Kuniya Tanaka; Kenichi Matsuo; Shinji Togo
Journal:  Langenbecks Arch Surg       Date:  2005-12-01       Impact factor: 3.445

2.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

Review 3.  Current treatment for liver metastases from colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

4.  Reoperation for recurrent colorectal cancer.

Authors:  Michael D Hellinger; Cesar A Santiago
Journal:  Clin Colon Rectal Surg       Date:  2006-11

5.  Percutaneous cryosurgery for the treatment of hepatic colorectal metastases.

Authors:  Ke-Cheng Xu; Li-Zhi Niu; Wei-Bing He; Yi-Zi Hu; Jian-Sheng Zuo
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

6.  Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity.

Authors:  Sergio A Dromi; Meghaan P Walsh; Sarah Herby; Bryan Traughber; Jianwu Xie; Karun V Sharma; Kiran P Sekhar; Alfred Luk; David J Liewehr; Matthew R Dreher; Terry J Fry; Bradford J Wood
Journal:  Radiology       Date:  2009-02-27       Impact factor: 11.105

7.  Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer.

Authors:  Kristin H Haraldsdóttir; Kjell Ivarsson; Karin Jansner; Unne Stenram; Karl-G Tranberg
Journal:  Cancer Immunol Immunother       Date:  2011-03-13       Impact factor: 6.968

8.  Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.

Authors:  M H M G M den Brok; R P M Sutmuller; S Nierkens; E J Bennink; C Frielink; L W J Toonen; O C Boerman; C G Figdor; T J M Ruers; G J Adema
Journal:  Br J Cancer       Date:  2006-09-05       Impact factor: 7.640

9.  Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses.

Authors:  Myriam N Bouchlaka; Gail D Sckisel; Danice Wilkins; Emanual Maverakis; Arta M Monjazeb; Maxwell Fung; Lisbeth Welniak; Doug Redelman; Alan Fuchs; Cahit A Evrensel; William J Murphy
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.